Cargando…
Structural and genetic basis for development of broadly neutralizing influenza antibodies
Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglut...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095019/ https://www.ncbi.nlm.nih.gov/pubmed/22932267 http://dx.doi.org/10.1038/nature11371 |
_version_ | 1783510581109587968 |
---|---|
author | Lingwood, Daniel McTamney, Patrick M. Yassine, Hadi M. Whittle, James R. R. Guo, Xiaoti Boyington, Jeffrey C. Wei, Chih-Jen Nabel, Gary J. |
author_facet | Lingwood, Daniel McTamney, Patrick M. Yassine, Hadi M. Whittle, James R. R. Guo, Xiaoti Boyington, Jeffrey C. Wei, Chih-Jen Nabel, Gary J. |
author_sort | Lingwood, Daniel |
collection | PubMed |
description | Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region IGHV1-69, after limited affinity maturation from their germline ancestors(1,2), but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref. 3), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G (IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural ‘patterns’ that provide a substrate for further affinity maturation. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nature11371) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7095019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70950192020-03-26 Structural and genetic basis for development of broadly neutralizing influenza antibodies Lingwood, Daniel McTamney, Patrick M. Yassine, Hadi M. Whittle, James R. R. Guo, Xiaoti Boyington, Jeffrey C. Wei, Chih-Jen Nabel, Gary J. Nature Article Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region IGHV1-69, after limited affinity maturation from their germline ancestors(1,2), but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref. 3), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G (IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural ‘patterns’ that provide a substrate for further affinity maturation. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nature11371) contains supplementary material, which is available to authorized users. Nature Publishing Group UK 2012-08-29 2012 /pmc/articles/PMC7095019/ /pubmed/22932267 http://dx.doi.org/10.1038/nature11371 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2012 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Lingwood, Daniel McTamney, Patrick M. Yassine, Hadi M. Whittle, James R. R. Guo, Xiaoti Boyington, Jeffrey C. Wei, Chih-Jen Nabel, Gary J. Structural and genetic basis for development of broadly neutralizing influenza antibodies |
title | Structural and genetic basis for development of broadly neutralizing influenza antibodies |
title_full | Structural and genetic basis for development of broadly neutralizing influenza antibodies |
title_fullStr | Structural and genetic basis for development of broadly neutralizing influenza antibodies |
title_full_unstemmed | Structural and genetic basis for development of broadly neutralizing influenza antibodies |
title_short | Structural and genetic basis for development of broadly neutralizing influenza antibodies |
title_sort | structural and genetic basis for development of broadly neutralizing influenza antibodies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095019/ https://www.ncbi.nlm.nih.gov/pubmed/22932267 http://dx.doi.org/10.1038/nature11371 |
work_keys_str_mv | AT lingwooddaniel structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies AT mctamneypatrickm structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies AT yassinehadim structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies AT whittlejamesrr structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies AT guoxiaoti structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies AT boyingtonjeffreyc structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies AT weichihjen structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies AT nabelgaryj structuralandgeneticbasisfordevelopmentofbroadlyneutralizinginfluenzaantibodies |